Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?
Ulf Andersson, William Ottestad, & Kevin J. Tracey
IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19
Yu Chen et al.
LncRNA PVT1 regulates atrial fibrosis via miR-128-3p-SP1-TGF-β1-Smad axis in atrial fibrillation
Feng Cao, Zhe Li, Wen-mao Ding, Ling Yan, & Qing-yan Zhao
Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
Huan Yang et al.
Gut microbiota promote the inflammatory response in the pathogenesis of systemic lupus erythematosus
Yiyangzi Ma, Xiaoxue Xu, Mengtao Li, Jun Cai, Qiang Wei, & Haitao Niu
Btk inhibitor ibrutinib reduces inflammatory myeloid cell responses in the lung during murine pneumococcal pneumonia
Alexander P. de Porto et al.
miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease
Jun-Ke Long, Wen Dai, Ya-Wen Zheng, & Shui-Ping Zhao
Post-sepsis syndrome – an evolving entity that afflicts survivors of sepsis
Zachary Mostel et al.
The neuroprotective mechanisms of ginkgolides and bilobalide in cerebral ischemic injury: a literature review
Zili Feng, Qian Sun, Wang Chen, Yu Bai, Daihua Hu, & Xin Xie
